Sequencing the Genome: Examining Modern Medicine
April 26, 2017
New York City
Our DNA is a chemical alphabet of A, T, C and G, which together create the book of life. The mapped human genome has opened up incredible possibilities and scientists say we’re on the cusp of the golden age of genomic-based, personalized medicine.
How is the genetic roadmap empowering the medical community to find breakthrough treatments? Where is personalized medicine headed? What are the issues that we as a society should anticipate moving forward?
At a forum in New York, The Atlantic gathered key stakeholders in this conversation to discuss the future of the genomic era.
Watch full session videos
To view photos from this event, please visit our Facebook page
Presented by
Speakers
-
![Karen Nelson]()
Karen Nelson President, J. Craig Venter Institute and Head of Microbiome Program for Longevity, Inc. @KarenKenelson -
![Edward Abrahams]()
Edward Abrahams President Personalized Medicine Coalition @permedcoalition -
![Ting Wu]()
Ting Wu Director and Co-Founder, Personal Genetics Education Project and Professor, Genetics, Harvard Medical School @pgEDorg -
![Paul Appelbaum]()
Paul Appelbaum Director, Center for Research on Ethical, Legal & Social Implications of Psychiatric, Neurologic & Behavioral Genetics and Elizabeth K. Dollard Professor, Columbia University @appelbap -
![Ripley Ballou]()
Ripley Ballou VP, GSK Vaccines; Head, Slaoui Center for Vaccines Research, Rockville MD @GSKUS -
![Claire Pomeroy]()
Claire Pomeroy President and CEO Albert and Mary Lasker Foundation @clairepomeroy -
![Steve Clemons]()
Steve Clemons Washington Editor at Large The Atlantic @SCClemons -
![James Hamblin]()
James Hamblin Senior Editor The Atlantic @jameshamblin -
![Robert J. Hugin*]()
Robert J. Hugin* Executive Chairman Celgene @Celgene -
![Arthur Caplan]()
Arthur Caplan Drs. William F. and Virginia Connolly Mitty Professor of Bioethics; Director, Division of Medical Ethics New York University Langone Medical Center @ArthurCaplan -
![Meg Tirrell*]()
Meg Tirrell* Biotech and Pharma Reporter CNBC @megtirrell -
![Aris Baras]()
Aris Baras Vice President and Co-Head Regeneron Genetics Center @regeneron -
![Mark Feinberg]()
Mark Feinberg President and CEO International AIDS Vaccine Initiative @IAVI
Agenda
- Wednesday, April 26
- 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
- 8:35 a.m.State of Innovation and ResearchClaire Pomeroy, President, Albert and Mary Lasker Foundation
With Steve Clemons, Washington Editor at Large, The Atlantic - 9:00 a.m. Dawn of the Genomic EraEdward Abrahams, President, Personalized Medicine Coalition
Karen Nelson, President, J. Craig Venter Institute
Aris Baras, Vice President, Regeneron Pharmaceuticals; Head, Regeneron Genetics Center
With James Hamblin, Senior Editor, The Atlantic - 9:30 a.m.The Future VaccineRipley Ballou, VP, GSK Vaccines; Head, Slaoui Center for Vaccines Research, Rockville MD
Mark Feinberg, President and CEO, International AIDS Vaccine Initiative
With Steve Clemons, The Atlantic - 10:00 a.m.The Business of Human Genomics* Produced by our underwriter PhRMA Robert J. Hugin, Executive Chairman, Celgene
With Meg Tirrell, Reporter, CNBC - 10:10 a.m.Opportunities and Challenges AheadPaul Appelbaum, Director, Center for Research on Ethical, Legal and Social Implications of Psychiatric, Neurological, and Behavioral Genetics; Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law at Columbia University
Ting Wu, Director and Co-Founder, Personal Genetics Education Project; Professor of Genetics, Harvard Medical School
Arthur Caplan, Director, Division of Medical Ethics, NYU School of Medicine; Drs. William F. and Virginia Connolly Mitty Professor of Bioethics
With James Hamblin, The Atlantic - 10:45 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE
